What You Should Know: Cowen Healthcare Investments announced the successful close of Cowen Healthcare Investments IV ("CHI IV" or the "Fund") with total committed capital of $555.6M. CHI IV will invest primarily in mid to late-stage life sciences opportunities.Led by Kevin Raidy, Tim Anderson, and Robert Sine, Cowen Healthcare Investments supports innovation in the healthcare sectors, with a particular focus on biopharma, diagnostics, and digital health.Since its founding in 2012, the CHI
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
UC Berkeley Bio Track Helps Faculty Launch Biotech Startups
What You Should Know: Berkeley SkyDeck, the global hub for entrepreneurship and a leading accelerator, today announced that it has welcomed the first three companies for its new SkyDeck LSEC Bio Track: AsparaGlue, Editpep, and MZR Neurotech.The inaugural track, created in partnership with the UC Berkeley Life Sciences Entrepreneurship Center (LSEC) through LSEC’s new Venture Grant Program, will assist the UC Berkeley faculty-led teams to launch their own biotech and life sciences
Read More
ODAIA Secures $25M for AI-Driven Commercial Insights Platform for Pharma
What You Should Know: ODAIA, developers of MAPTUAL, an AI-powered commercial insights SaaS platform for pharmaceutical companies, announced it raised an oversubscribed $25 Million Series B financing round, led by Threshold Ventures and co-led by Monograph Capital. Wittington Ventures also joined, with participation from existing investors Flint Capital, BDC Capital, StandUp Ventures and Graphite Ventures. Emily Melton, Managing Partner of Threshold Ventures and Charles Conn, co-founder and
Read More
Sanofi & Flatiron Health Partner to Redesign Clinical Trial Experience for Sponsors
What You Should Know: Flatiron Health announced a new partnership today with Sanofi in their pursuit to redesign the clinical trial experience for sponsors, sites, and patients in the therapeutic area of oncology. The multi-study partnership between Sanofi and Flatiron will focus on improving clinical trial data acquisition, delivery, and quality through site-facing technology that digitally transfers data captured in the electronic health record (EHR) directly into the electronic data
Read More
Quest Diagnostics Acquires Haystack Oncology for $300M in Cash
What You Should Know: Quest Diagnostics has reached an agreement to acquire Haystack Oncology an early-stage oncology company focused on minimal residual disease (MRD) testing to aid in the early, accurate detection of residual or recurring cancer and better inform therapy decisionsUnder the terms of the agreement, Quest will pay $300 million in cash at closing, net of cash acquired, and up to an additional $150 million on achieving future performance
Read More
Komodo Health Launches MapEnhance; Changing the Paradigm for Health Data Utilization
What You Should Know: Komodo Health unveils MapEnhance, a network of speciality data partners that seamlessly connects new datasets — including genomic, lab, cost and clinical insights — to Komodo's Healthcare Map, to drive faster and timelier insights across healthcare and Life Sciences.With MapEnhance, Komodo is bringing the industry a more seamless way to leverage clinical intelligence and customize data inputs from a variety of real-world data sources,
Read More
Drug Discovery Outsourcing Market Expected to Reach $7.5B by 2033
What You Should Know: The drug discovery outsourcing market is expected to reach $3.75B in 2023 and is expected to grow at a steady CAGR of 7.2% and is expected to reach $7.52B by 2033, according to a new report by Future Market Insights.The research report on the drug discovery outsourcing market states that the pharmaceutical industry is expanding thoroughly with new extensions and high-end research programs. AI Drug Discovery Outsourcing for Cost-Savings The
Read More
Biostage Raises $6M to Advance Clinical Trials
What You Should Know: Biostage, Inc., a cell-therapy biotechnology company with successful first-in-human experience in treating esophageal cancer and FDA approval to commence a clinical trial of the Biostage Esophageal Implant raises $6M from new and existing investors in a private placement of its shares of common stock.The funds will be used to accelerate the clinical development of Biostage’s lead product candidate, the Biostage Esophageal Implant, or BEI. The FDA has approved a
Read More
PsychoGenics Launches AI Platform to Revolutionize Drug Discovery
What You Should Know: - PsychoGenics Inc., a provider of AI-enabled phenotypic drug discovery and preclinical CRO services launches eCube®, a novel pharmaco-electroencephalography (“pharmacoEEG”) platform. The platform supports phenotypic drug discovery, which unlike traditional target-based drug discovery, can identify novel treatments with multiple targets. How eCube Works eCube measures drug-induced changes to EEG spectra data and utilizes machine learning classifiers trained
Read More
Exec Hires: Clinical Trials Marketplace SubjectWell Appoints New CEO
What You Should Know: - SubjectWell, the largest engagement platform for matching patients with chronic health conditions to new care options, announced that clinical industry veteran Fred Martin has joined SubjectWell as CEO. - Fred will joins SubjectWell during a time of growth following the company’s Series B funding in November 2022, with the goal of accelerating technical solutions and building investor relations. Fred Martin Bio Fred brings more than 25 years of experience in
Read More